marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Cocrystal Pharma Balance Sheet 2011-2024 | COCP
Annual Balance Sheet Cocrystal Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-24.5 M | -36.9 M | -58.5 M | -32.4 M | -6.6 M | -2.39 M | 259 K | -3.64 M | -9.28 M | -3.97 M | -589 K | 4.49 M | 2.88 M |
Long Term Debt |
1.61 M | 57 K | 7 K | - | - | - | 1.01 M | - | - | - | - | 2.89 M | 3.04 M |
Long Term Debt Current |
240 K | 233 K | 209 K | 178 K | 177 K | - | - | - | - | - | - | 182 K | 261 K |
Total Non Current Liabilities |
1.61 M | 57 K | 298 K | 379 K | 537 K | 117 K | 14.6 M | 20.5 M | 49.9 M | 243 M | - | 2.89 M | 3.04 M |
Total Current Liabilities |
3.26 M | 1.22 M | 1.54 M | 1.36 M | 2.29 M | 1.56 M | 1.41 M | 2.04 M | 6.7 M | 9.16 M | 12.5 M | 7.93 M | 7.28 M |
Total Liabilities |
4.88 M | 1.27 M | 1.84 M | 1.74 M | 2.82 M | 1.67 M | 16 M | 22.6 M | 56.6 M | 253 M | 12.5 M | 10.8 M | 10.3 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-316 M | -298 M | -259 M | -245 M | -235 M | -187 M | -138 M | -137 M | -62.6 M | -12.4 M | -33.7 M | -14.1 M | -6.16 M |
Total Assets |
31.3 M | 40.8 M | 79.4 M | 54.2 M | 28.5 M | 68.6 M | 121 M | 125 M | 224 M | 259 M | 6.46 M | 7.24 M | 7.55 M |
Cash and Cash Equivalents |
26.4 M | 37.1 M | 58.7 M | 33 M | 7.42 M | 2.72 M | 748 K | 3.64 M | 9.28 M | 3.97 M | 1.03 M | 8.1 K | 416 K |
Book Value |
26.4 M | 39.6 M | 77.5 M | 52.5 M | 25.7 M | 66.9 M | 105 M | 102 M | 168 M | 6.65 M | -6.03 M | -3.58 M | -2.77 M |
Total Shareholders Equity |
26.4 M | 39.6 M | 77.5 M | 52.5 M | 25.7 M | 66.9 M | 105 M | 102 M | 168 M | 6.65 M | -8.83 M | -3.58 M | -2.77 M |
All numbers in USD currency
Quarterly Balance Sheet Cocrystal Pharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.58 M | 1.53 M | 1.58 M | 1.61 M | - | 10 K | 27 K | 57 K | 119 K | 177 K | 234 K | 7 K | 14 K | 21 K | 28 K | 34 K | 34 K | 34 K | 34 K | 14 K | 14 K | 14 K | 14 K | 117 K | 117 K | 117 K | 117 K | 1.01 M | 1.01 M | 1.01 M | 1.01 M | - | - | - | - | 49.9 M | - | - | - | 65.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 1.53 M | 1.58 M | 1.61 M | - | - | 27 K | 57 K | 119 K | 177 K | 234 K | 298 K | 358 K | 290 K | 336 K | 379 K | 379 K | 379 K | 379 K | 537 K | 537 K | 537 K | 537 K | 117 K | 117 K | 117 K | 117 K | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 65.3 M | 7.24 M | 65.3 M | 65.3 M | 23 K | - | 23 K | 23 K | - | - | - | - | - | - | - | - |
Total Liabilities |
3.53 M | 4.18 M | 3.96 M | 4.88 M | 1.92 M | 1.6 M | 3.17 M | 1.27 M | 1.74 M | 2.99 M | 1.79 M | 1.84 M | 1.59 M | 2.67 M | 1.79 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | 2.82 M | 2.82 M | 2.82 M | 2.82 M | 1.67 M | 1.67 M | 1.67 M | 1.67 M | 16 M | 16 M | 16 M | 16 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 56.6 M | 56.6 M | 56.6 M | 56.6 M | 74.4 M | 74.4 M | 74.4 M | 74.4 M | 386 K | 386 K | 386 K | 386 K | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-330 M | -325 M | -320 M | -316 M | -311 M | -307 M | -303 M | -298 M | -293 M | -288 M | -263 M | -259 M | -255 M | -251 M | -248 M | -245 M | -245 M | -245 M | -245 M | -235 M | -235 M | -235 M | -235 M | -187 M | -187 M | -187 M | -187 M | -138 M | -138 M | -138 M | -138 M | -137 M | -137 M | -137 M | -137 M | -62.6 M | -62.6 M | -62.6 M | -62.6 M | -12.4 M | -12.4 M | -12.4 M | -12.4 M | -12.3 M | -12.3 M | -12.3 M | -15.6 M | -14.1 M | -14.1 M | -14.1 M | -14.1 M | -6.16 M | -6.16 M | -6.16 M | -6.16 M |
Total Assets |
16.2 M | 21.6 M | 26.5 M | 31.3 M | 32.6 M | 36.3 M | 37.8 M | 40.8 M | 45.6 M | 52.4 M | 75.4 M | 79.4 M | 82.6 M | 87.4 M | 53.9 M | 54.2 M | 54.2 M | 54.2 M | 54.2 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 68.6 M | 68.6 M | 68.6 M | 68.6 M | 121 M | 121 M | 121 M | 121 M | 125 M | 125 M | 125 M | 125 M | 224 M | 224 M | 224 M | 224 M | 259 M | 259 M | 259 M | 259 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | 7.24 M | 7.24 M | 7.24 M | 7.24 M | 7.55 M | 7.55 M | 7.55 M | 7.55 M |
Cash and Cash Equivalents |
13 M | 18.1 M | 21.8 M | 26.4 M | 29.7 M | 32.4 M | 34 M | 37.1 M | 42.1 M | 51 M | 54.8 M | 58.7 M | 61.6 M | 67.1 M | 33.3 M | 33 M | 33 M | 33 M | 33 M | 7.42 M | 7.42 M | 7.42 M | 7.42 M | 2.72 M | 2.72 M | 6.84 M | 1.25 M | 748 K | 1.34 M | 3.45 M | 748 K | 3.6 M | 3.64 M | 3.64 M | 3.64 M | 9.28 M | 9.28 M | 9.28 M | 9.28 M | 3.97 M | 3.97 M | 3.97 M | 3.97 M | 1.03 M | 1.03 M | 1.03 M | 1.03 M | 4.72 M | 62.3 K | 62.3 K | 62.3 K | 35.4 K | 416 K | 416 K | 416 K |
Book Value |
12.7 M | 17.4 M | 22.6 M | 26.4 M | 30.7 M | 34.7 M | 34.7 M | 39.6 M | 43.9 M | 49.4 M | 73.6 M | 77.5 M | 81 M | 84.7 M | 52.1 M | 52.5 M | 52.5 M | 52.5 M | 52.5 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M | 66.9 M | 66.9 M | 66.9 M | 66.9 M | 105 M | 105 M | 105 M | 105 M | 102 M | 102 M | 102 M | 102 M | 168 M | 168 M | 168 M | 168 M | 185 M | 185 M | 185 M | 185 M | 1.28 M | 1.28 M | 1.28 M | 1.28 M | 7.24 M | 7.24 M | 7.24 M | 7.24 M | 7.55 M | 7.55 M | 7.55 M | 7.55 M |
Total Shareholders Equity |
12.7 M | 17.4 M | 22.6 M | 26.4 M | 30.7 M | 34.7 M | 34.7 M | 39.6 M | 49.9 M | 49.4 M | 73.6 M | 77.5 M | 81 M | 84.7 M | 52.1 M | 52.5 M | 52.5 M | 52.5 M | 52.5 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M | 66.9 M | 66.9 M | 66.9 M | 66.9 M | 105 M | 105 M | 105 M | 105 M | 102 M | 102 M | 102 M | 102 M | 168 M | 168 M | 168 M | 168 M | 6.65 M | 6.65 M | 6.65 M | 6.65 M | -8.83 M | -8.83 M | -8.83 M | -8.83 M | -5.01 M | -3.58 M | -3.58 M | -3.58 M | -2.77 M | -2.77 M | -2.77 M | -2.77 M |
All numbers in USD currency